Israel's Smoking Problem: The Shift towards E-Cigarettes

Dec.12.2022
Israel's Smoking Problem: The Shift towards E-Cigarettes
Israel struggles to quit smoking as smoking rates remain unchanged at 20% despite the global shift towards e-cigarettes.

It seems that Israelis can't quit smoking. According to the Ministry of Health, the percentage of smokers in Israel has remained at 20% for many years, despite a steady increase in population. This means that the number of smokers in Israel is rising in proportion to the country's population.


It seems odd that, while many other developed countries around the world are turning to more innovative tobacco consumption methods, Israel still relies heavily on combustible cigarettes. Despite being known for its innovative solutions to a wide range of issues, why is Israel so far behind other developed countries in reducing smoking?


According to the global tobacco product manufacturer and leading cigarette supplier in Israel, Philip Morris International, the answer lies in taxation.


From a business standpoint, PMI aims to make profits, but the company has recognized ominous signs that electronic cigarettes seem to be the primary way of tobacco consumption in the future. PMI's objective is to stay ahead in this shift and has announced ambitions to have smoke-free products contribute to more than 50% of its total net revenue by 2025.


A few years ago, Philip Morris decided to undergo a dramatic and potentially historic change in regards to a global tobacco company. "Our vision for a smoke-free future could impact over 1 billion adult smokers worldwide," said Roi Amit, the general manager of PMI Israel. "PMI has made it clear that if you don't smoke, don't start. If you do smoke, quit. If you won't quit, then switch. Our goal is to develop advanced technology based on scientific research that minimizes the impact of traditional cigarettes (which rely on burning tobacco) and offers it as an alternative for adult smokers who aren't able to quit. Today, the company's resources are largely focused on realizing this vision.


PMI has made it clear that if you don't smoke, don't start. If you do smoke, quit. If you won't give it up, then change. The company's objective is to develop advanced alternatives based on scientific research in order to reduce the impact of traditional combustible cigarettes as much as possible and offer them as an alternative for adult smokers who cannot or will not quit. Currently, the majority of the company's resources are devoted to achieving this vision.


I'm sorry, but "王阿密" is not a phrase or sentence that can be translated to journalistic English. It appears to be a proper noun or name, which cannot be translated without additional context. Please provide more information or a complete sentence for translation.


All tobacco use is harmful, but smoke is the worst part.


However, electronic cigarettes with nicotine are also harmful to you. Based on experience, they are detrimental to your health.


While smoking is harmful, electronic cigarettes may have some marginal advantages as they can lower the risk of nicotine poisoning and exposure to harmful chemicals through inhalation for both the user and those around them, according to some studies. PMI hopes that smokers will switch to e-cigarettes if they are already smoking.


An independent study conducted by the UK government's public health agency, Public Health England, and the Royal College of Physicians advisory committee on tobacco shows that vaping is 95% healthier than smoking. However, other experts claim that e-cigarettes are just as dangerous as traditional smoking.


During an interview with the Jerusalem Post, Amit and several other PMI executives admitted that smoking is not healthy.


But when asked if PMI has considered completely stopping cigarette production - given how aware they are of the significant dangers of cigarettes - they stated that if they were to immediately cease cigarette production, one of the other leading cigarette brands in the market would quickly fill the gap.


They do not want this situation to occur and instead, they aim to use their market share to their advantage and gradually encourage people to move away from cigarettes, whether produced by them or anyone else, and turn to electronic cigarette products, preferably theirs. However, they first need to address a major obstacle hindering their progress: Israeli regulatory agencies.


Philip Morris International (PMI) is reportedly putting pressure on Israeli regulators to change their strict stance on taxing e-cigarettes. PMI argues that this is one of the main reasons why smoking rates in Israel have remained unchanged, despite the global trend towards decreasing tobacco use.


Situation of Electronic Cigarette Tax


In Japan, as of 2020, the overall tax on combustible cigarettes is 61 percent; the tax rate on heated tobacco products (HTP) is 52.14 percent. The 19 percent difference in tobacco and HTP taxes has played a significant role in prompting over 22 percent of adult male smokers to turn to less healthy options.


Similarly, in Denmark (where support for HTP stands at 154%), the UK (73%), Germany (123%), Italy (107%), and other countries, the number of smokers has declined in line with more favorable taxation for heated tobacco products.


As previously mentioned, the percentage of smokers in Israel has remained consistent (resulting in an increase in the number of smokers with population growth). Why is this the case?


Israel is the only country out of 39 OECD nations that imposes a tax rate on heated tobacco products (HTP) six percent higher than combustible cigarettes. This unique position among these countries provides a strong argument for PMI's case.


To succeed on the journey towards a smoke-free world, many things need to be done, and in other countries, these things are happening; but in Israel, they are not," Amit said. In this sense, he noted, "Israel has failed in areas where other countries have succeeded.


I don't blame the Ministry of Health. They have tried, but what I mean is that we should do more. To accelerate progress, public health agencies should partner with the tobacco industry to advance the concept of reducing tobacco harm in Israel. Combining higher safety standards, stricter enforcement, and prevention of sales to young people and adolescents - as is the strategy in other countries - regulators are called upon here to develop a local strategy for smoking products based on reducing harm caused by combustibles, and encourage alternatives to those who cannot quit smoking.


2FIRSTS will continue to track and report on this topic, with further updates available on the '2FIRSTSAPP.' Scan the QR code below to download the app.



Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

South Korea Fully Reviews Nicotine-Analog and Nicotine-Free Vape Liquid Imports, With Over 99% From China and Chinese Supply-Chain Documents Under Scrutiny
South Korea Fully Reviews Nicotine-Analog and Nicotine-Free Vape Liquid Imports, With Over 99% From China and Chinese Supply-Chain Documents Under Scrutiny
Korea Customs Service has tightened import controls on nicotine-analog and nicotine-free e-cigarette liquids, placing the products under 100% document review and subjecting all e-cigarette liquid import declarations to pre-clearance ingredient analysis. As of September 20, 2026, South Korea had imported about 15 metric tons of nicotine-analog liquids, 99.99% from China, and about 316 metric tons of nicotine-free liquids, including roughly 315 metric tons, or 99.7%, from China. The measures follow South Korea's April expansion of its tobacco definition to include synthetic nicotine products and include new checks on Chinese manufacturing, transaction and export documentation.
Sep.24
JTI Proposes 25-Cent Irish Cigarette Tax Increase, Says It Could Raise €45 Million
JTI Proposes 25-Cent Irish Cigarette Tax Increase, Says It Could Raise €45 Million
Japan Tobacco International's Irish business has proposed a €0.25 tax increase on a pack of 20 cigarettes in its pre-Budget 2027 submission, below the €0.50-or-more increases typically imposed in recent Irish budgets. JTI says the proposal could generate around €45 million in additional Exchequer revenue while limiting further movement toward illicit and non-Irish-tax-paid tobacco. Revenue's existing estimate for a comparable €0.25 increase, including pro-rata rises on other tobacco products, is about €18 million for a full year.
JTI
Sep.18 by 2Firsts Perspectives
2Firsts Data|China’s Vape-Related Exports Rose 3.3% in August 2026 as UK Shipments Jumped 51.4% and U.S. Exports Fell 12.4%
2Firsts Data|China’s Vape-Related Exports Rose 3.3% in August 2026 as UK Shipments Jumped 51.4% and U.S. Exports Fell 12.4%
China exported $979 million of vape-related products in August 2026, up 3.3% from a year earlier but down 6.4% from July. The UK replaced the U.S. as the main source of growth: UK-bound shipments jumped 51.4% to a 2026 high of $177 million, while exports to the U.S. fell 12.4% to $339 million. Shipments to markets outside the U.S. increased 14.2%, broadening growth beyond the market that had driven July’s rebound.
News
Sep.23 by 2Firsts Perspectives
Canada Considers Easing Pharmacy-Only Nicotine Pouch Sales Rules, Potentially Reopening Convenience Store Channel
Canada Considers Easing Pharmacy-Only Nicotine Pouch Sales Rules, Potentially Reopening Convenience Store Channel
Canada's federal government is considering changes to current restrictions on where nicotine pouches can be sold, potentially allowing authorized products to return to convenience stores and other general retail channels, although no decision has been made. Since 2024, emerging nicotine replacement therapy products such as nicotine pouches have been largely restricted to behind-the-counter pharmacy sales. Health Canada, meanwhile, continues to recall unauthorized and higher-strength nicotine pouches, indicating that the current discussion concerns retail access for authorized products rather than a broad relaxation of nicotine pouch regulation.
Sep.14
FRE and ALP Push Modern Oral to 48% of Q2 Sales as Turning Point Brands Changes CEO and Lowers Profit-Guidance Ceiling
FRE and ALP Push Modern Oral to 48% of Q2 Sales as Turning Point Brands Changes CEO and Lowers Profit-Guidance Ceiling
Turning Point Brands said Executive Chairman David E. Glazek will become CEO on October 1, replacing Graham Purdy, who is stepping down for personal reasons. The company narrowed its 2026 adjusted EBITDA outlook to $70 million-$80 million from $70 million-$90 million while maintaining Modern Oral gross sales guidance of $330 million-$350 million and net sales guidance of $260 million-$270 million. In the second quarter, Modern Oral net sales rose 128% to $68.4 million and accounted for 48% of company-wide net sales. Adjusted EBITDA fell 50% year over year. TPB shares closed about 10% lower on September 21.
Market
Sep.22 by 2Firsts Perspectives
FDA Revises Import Alert 98-07 Rules, Bringing May Enforcement Priorities Into Unauthorized ENDS Detentions
FDA Revises Import Alert 98-07 Rules, Bringing May Enforcement Priorities Into Unauthorized ENDS Detentions
The U.S. Food and Drug Administration has revised the rules under Import Alert 98-07 to incorporate its May 2026 enforcement-priority policy for certain electronic nicotine delivery systems marketed without premarket authorization. The alert continues to allow detention without physical examination, or DWPE, for ENDS lacking required marketing authorization, while directing field divisions to apply the May risk-based framework. When necessary, detention or refusal decisions must also undergo review by the FDA's Center for Tobacco Products. Products including PACHA and Vuse Pro have already emerged as industry examples of the May policy, although enforcement discretion does not constitute FDA marketing authorization.
News
Sep.28 by 2Firsts Perspectives